Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

345 Neoantigen-targeted adoptive cell therapy in bladder cancer: feasibility of isolating and enriching tumor-reactive infiltrating lymphocytes

  • Mary Thomas1
  • Shari Pilon-Thomas2
  • Matthew Beatty3
  • Alex Alfaro1
  • Sarah Bazargan4
  • Fatema Khambati5
  • Johannes Ali5
  • Nicholas Couchara6
  • Emily Bauer1
  • Olivia Steinberg7
  • Mitch W Braun6
  • Madeline Rodriguez Valentin8
4 more authors
  • Isaac R Calle-Toral6
  • Michael I Carter6
  • Katarzyna A Rejniak6
  • Michael A Poch6
8 affiliations
  1. 11Moffitt Cancer Center, Tampa, FL, USA
  2. 21H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
  3. 32H. Lee Moffitt Cancer Center, Tampa, FL, USA
  4. 42Moffitt Cancer Center/University of South Florida, Ormond Beach, FL, USA
  5. 5H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
  6. 6H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
  7. 7Department of Occupational Science & Occupational Therapy (OS&OT), Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
  8. 8Moffitt Cancer Center, Seffner, FL, USA
Open at sourcePDFDOICite

Related

  1. Enriching microlaser-labelled cells by commercial flow cytometry-based cell sorting systems
    M. Koenig, T. T. Plaskocinski, A. Popczyk +7
    bioRxivPreprintCC BYFull textSystems & synthetic biologybioRxiv
  2. LKMHCpan: Transformer-optimized HLA-I pseudo-sequences enhance neoantigen prediction for immunotherapy
    Qing Li, Sanyang Liu, Mingyue Yao +5
    iSciencePeer-reviewedCC BY-NC-ND 4.0Bioinformatics & computational biologyImmunologyCrossrefCell Press
  3. NeoOmni Atlas: an integrated database for pan-cancer neoantigen derived from proteogenomics analysis
    T. Zheng, Z. Ran, J. Zeng +10
    bioRxivPreprintAll rights reservedFull textBioinformatics & computational biologybioRxiv
  4. Digitally enriching a high-risk population for pancreatic cancer using routine blood-based measures and clinical histories
    Chris Varghese, Leo Y. Li-Han, Richa Bisht +10
    arXivPreprintCC BY-NC-SA 4.0Full textBioinformatics & computational biologyarXiv
  5. Isolating domain-specific and domain-general contributions to global confidence
    Sophie Bavard, Andrew McWilliams, Flora Chartier +3
    PsyArXivPreprintCC BY 4.0Full textNeuroscienceOSF

Cite

BibTeXRIS
BibTeX
@article{thomas2026neoantigentargeted,
  title = {{345 Neoantigen-targeted adoptive cell therapy in bladder cancer: feasibility of isolating and enriching tumor-reactive infiltrating lymphocytes}},
  author = {Mary Thomas and Shari Pilon-Thomas and Matthew Beatty and Alex Alfaro and Sarah Bazargan and Fatema Khambati and Johannes Ali and Nicholas Couchara and Emily Bauer and Olivia Steinberg and Mitch W Braun and Madeline Rodriguez Valentin and Isaac R Calle-Toral and Michael I Carter and Katarzyna A Rejniak and Michael A Poch},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0345},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0345},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 345 Neoantigen-targeted adoptive cell therapy in bladder cancer: feasibility of isolating and enriching tumor-reactive infiltrating lymphocytes
AU  - Mary Thomas
AU  - Shari Pilon-Thomas
AU  - Matthew Beatty
AU  - Alex Alfaro
AU  - Sarah Bazargan
AU  - Fatema Khambati
AU  - Johannes Ali
AU  - Nicholas Couchara
AU  - Emily Bauer
AU  - Olivia Steinberg
AU  - Mitch W Braun
AU  - Madeline Rodriguez Valentin
AU  - Isaac R Calle-Toral
AU  - Michael I Carter
AU  - Katarzyna A Rejniak
AU  - Michael A Poch
PY  - 2026
DA  - 2026/11/04
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0345
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0345
SN  - 2051-1426
ER  -